Carcinogen DNA adducts and the risk of colon cancer: case–control study
- 1 January 2008
- journal article
- Published by Taylor & Francis Ltd in Biomarkers
- Vol. 13 (2), 201-216
- https://doi.org/10.1080/13547500701775449
Abstract
Colorectal cancer represents 8.5% of all tumours at the King Faisal Specialist Hospital & Research Centre. Environmental and dietary carcinogens such as polycyclic aromatic hydrocarbons (PAHs) and heterocyclic amines (HCAs) have long been suspected to play a prominent role in colon cancer aetiology. We designed a case-control study to test the hypothesis of whether or not the presence of DNA adducts can play a role in the aetiology of colon cancer. DNA adducts were measured in 24 cancerous and 20 non-cancerous tissue samples of newly diagnosed colon cancer patients by (32)P-post-labelling technique. Normal tissue from 19 hospital patients served as controls. The mean levels of adducts per 10(10) nucleotides in cancerous and non-cancerous tissue were 151.75+/-217.27 and 114.81+/-186.10, respectively; however, only adducts in cancerous tissue were significantly higher than controls (32.78+/-57.51 per 10(10) nucleotides) with p-values of 0.017. No BPDE-DNA adducts were found. No relationship was found between urinary cotinine as a marker of tobacco smoke and 1-hydroxypyrene as an indicator of an individual's internal dose of PAHs and DNA adducts. In a logistic regression model, only adducts in cancerous tissue were associated with the subsequent risk of colon cancer, with an odds ratio of 3.587 (95% confidence interval 0.833-15.448) after adjustment for age and the duration of living in the current region, but of a borderline significance (p=0.086). Although it is difficult to arrive at a definite conclusion from a small dataset, our preliminary results suggest the potential role of DNA adducts in the colon carcinogenesis process. Additional studies with larger sample sizes are needed to confirm our preliminary finding. It is also important to identify the structural characterization of these unknown DNA adducts in order to have a better understanding of whether or not environmental carcinogens play a role in the aetiology of colon cancer.This publication has 66 references indexed in Scilit:
- Genetic studies of diseasesCellular and Molecular Life Sciences, 2007
- Genetic Alterations in Sporadic and Hereditary Colorectal Cancer: Implementations for Screening and Follow-UpDigestive Diseases, 2007
- Tobacco Smoking and Colorectal Hyperplastic and Adenomatous PolypsCancer Epidemiology, Biomarkers & Prevention, 2006
- GSTM1 and GSTT1 Polymorphisms, Cigarette Smoking, and Risk of Colon Cancer: A Population-based Case-control Study in North Carolina (United States)Cancer Causes & Control, 2006
- Bladder Tumor Contains Higher N7-Methylguanine Levels in DNA than Adjacent Normal Bladder EpitheliumCancer Epidemiology, Biomarkers & Prevention, 2006
- Detection of 2-amino-1-methyl-6-phenylimidazo [4,5-b]-pyridine (PhIP)–DNA adducts in human pancreatic tissuesBiomarkers, 2006
- DNA adducts, DNA repair genotype/phenotype and cancer riskMutation research. Reviews in mutation research, 2005
- Age-related Changes in Oxidative DNA Damage and Benzo(a)pyrene Diolepoxide-I (BPDE-I)-DNA Adduct Levels in Human StomachJournal of Toxicology and Environmental Health, Part A, 2005
- Metabolic activation of polycyclic and heterocyclic aromatic hydrocarbons and DNA damage: A reviewToxicology and Applied Pharmacology, 2005
- Tobacco smoking using a waterpipe: a re-emerging strain in a global epidemicTobacco Control, 2004